Figure 5.
Clinical outcomes in non-sequential treatment. (A) OS in T and R groups; (B) PFS in T and R groups. Abbreviations: OS, overall survival; PFS, progression-free survival; T, trifluridine/tipiracil; R, regorafenib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.